Phase 2 Ulcerative Colitis (UC) trials recruiting now

All Ulcerative Colitis (UC) trials, every phase

Other phases for Ulcerative Colitis (UC)

Phase 2 Ulcerative Colitis (UC) trials

• A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
  NCT07113522 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 132 locations
• A Phase Ib/IIa Study of INT-210 Capsules in Participants With Active Ulcerative Colitis
  NCT07692165 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 15 locations
• A Study for HSK47388 in Participants With Ulcerative Colitis
  NCT07335055 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• A Study of MB-001 in Moderately to Severely Active Ulcerative Colitis
  NCT07374471 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Desloratadine in Patients With Ulcerative Colitis
  NCT07333716 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• FAPi-PET Imaging of in Vivo Fibrosis in Inflammatory Bowel Disease Patients
  NCT06604260 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Fecal Microbiota Transplantation for Ulcerative Colitis Using Dai and Han Donors
  NCT07814456 · Phase: Phase 2 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 1 location
• Fluorescence Imaging of Risankizumab-800CW in Inflammatory Bowel Disease
  NCT06606808 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Impact Of The Gut Microbiota On Host Cells Energy Metabolism in Health And In Inflammatory Bowel Disease
  NCT07300553 · Phase: Phase 2 · Ages: 18 Years to 50 Years · Sex: All (male and female) · 2 locations
• LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
  NCT07415044 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 259 locations
• Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative Colitis
  NCT06850727 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 32 locations
• Selenium Supplementation in Moderate-Severely Active Ulcerative Colitis Patients Treated With Advanced Therapies
  NCT07427017 · Phase: Phase 2 · Ages: 18 Years to 85 Years · Sex: All (male and female) · 1 location
• Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
  NCT06619990 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 98 locations
• Study of the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of BCD-261 in Subjects With Moderate to Severe Active Ulcerative Colitis
  NCT07080034 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 20 locations
• The Purpose of This Study is to Evaluate the Efficacy and Safety of 627 in the Treatment of UC
  NCT07507513 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Unravelling Intestinal Fibrosis in Ulcerative Colitis
  NCT06604273 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

What does Phase 2 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.